Piramal Phytocare Limited has informed the Exchange that the Company has fixed Record Date as December 12, 2019 for the purpose of ascertaining the shareholders of PPL who shall be entitled to receive equity shares of PEL.

Piramal Phytocare Limited is a research-driven drug company which focuses on therapeutic areas such as Cancer, Diabetes, Inflammation and Infectious Diseases.

Record Date

Piramal Phytocare Limited has informed the Exchange about Amalgamation/Merger

Amalgamation/Merger

Piramal Phytocare Limited has informed the Exchange regarding Compliance under Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations )

Related Party Transactions

Piramal Phytocare Limited has informed the Exchange regarding Resignation of Mr Ankit Kotak as Chief Financial Officer of the company w.e.f. November 05, 2019.

Resignation

Piramal Phytocare Limited has informed the Exchange regarding Revised Unaudited Financial Results for the quarter and half year ended September 30, 2019.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Piramal Phytocare (PPHL IN)

Record Date

Amalgamation/Merger

Related Party Transactions

Resignation

Financial Results Updates

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)